- Home
- VRAX vs DSS Comparison
VRAX vs DSS Comparison
Compare VRAX & DSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VRAX
- DSS
- Stock Information
- Founded
- VRAX 2013
- DSS 1984
- Country
- VRAX United Kingdom
- DSS United States
- Employees
- VRAX N/A
- DSS N/A
- Industry
- VRAX Biotechnology: In Vitro & In Vivo Diagnostic Substances
- DSS Containers/Packaging
- Sector
- VRAX Health Care
- DSS Consumer Discretionary
- Exchange
- VRAX Nasdaq
- DSS Nasdaq
- Market Cap
- VRAX 9.1M
- DSS 7.3M
- IPO Year
- VRAX 2022
- DSS N/A
- Fundamental
- Price
- VRAX $2.14
- DSS $0.85
- Analyst Decision
- VRAX
- DSS
- Analyst Count
- VRAX 0
- DSS 0
- Target Price
- VRAX N/A
- DSS N/A
- AVG Volume (30 Days)
- VRAX 487.9K
- DSS 31.9K
- Earning Date
- VRAX 02-05-2025
- DSS 11-13-2024
- Dividend Yield
- VRAX N/A
- DSS N/A
- EPS Growth
- VRAX N/A
- DSS N/A
- EPS
- VRAX N/A
- DSS N/A
- Revenue
- VRAX $84,872.00
- DSS $25,019,000.00
- Revenue This Year
- VRAX $5,169.18
- DSS N/A
- Revenue Next Year
- VRAX $66.97
- DSS N/A
- P/E Ratio
- VRAX N/A
- DSS N/A
- Revenue Growth
- VRAX 7.03
- DSS N/A
- 52 Week Low
- VRAX $0.60
- DSS $0.81
- 52 Week High
- VRAX $9.00
- DSS $2.30
- Technical
- Relative Strength Index (RSI)
- VRAX 49.68
- DSS 41.29
- Support Level
- VRAX $2.03
- DSS $0.89
- Resistance Level
- VRAX $2.33
- DSS $0.99
- Average True Range (ATR)
- VRAX 0.39
- DSS 0.08
- MACD
- VRAX -0.04
- DSS -0.00
- Stochastic Oscillator
- VRAX 21.48
- DSS 0.00
About VRAX Virax Biolabs Group Limited
Virax Biolabs Group Ltd is a biotechnology company focused on the prevention, detection, diagnosis and risk management of viral diseases that also engages in distribution of diagnostics test kits of various viral threats. It is developing a proprietary T-Cell Test technology with the intention of providing an immunology profiling platform that assesses each individual's immune risk profile against world-wide viral threats. T-Cell testing is particularly effective in the diagnosis and therapeutics of COVID-19 as well as other threats including Hepatitis B, Malaria, Herpes and Human Papillomavirus.
About DSS DSS Inc.
DSS Inc is operating a business focused on Five operating segments Product Packaging, Biotechnology, Commercial Lending, Securities and Investment Management, and Direct Marketing. Currently operates five distinct business lines operate around the globe with primary operations in North America and Asia.